Los Angeles, CA
Le Meridien Pasadena Arcadia
February 27-28,  2026
8.0 CE/CME & ABPath MOC Available

Two Days. One Mission. Transforming Precision Cancer Care.

Los Angeles, CA
February 27-28, 2026

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Los Angeles

In the heart of Southern California’s biomedical corridor, this conference—presented in partnership with City of Hope—unites oncologists and pathologists  to explore breakthroughs transforming precision cancer care. Co-chaired by Dr. Stephen Gruber, Vice President of City of Hope National Medical Center, and Dr. Eric F. Glassy, Medical Director of Affiliated Pathologists Medical Group, the program highlights how integrated diagnostic insights and therapy selection are improving outcomes—while fostering meaningful connections across the West Coast. Earn free CE/CME & MOC credits as you engage in thought-provoking discussions that bridge science and clinical practice.

Be part of this integrated, multidisciplinary program that connects diagnostic discovery to therapeutic impact—advancing the future of precision cancer care.

Agenda

EVENT PARTNER

February 27, 2026
9:00 AMRegistration/Check-in/Breakfast
9:50 AMWelcome and Introductions
10:00 AMNeoadjuvant – Dynamic Neoadjuvant Treatment for Breast Cancer: Using Radiologic Response and Biomarkers to Tailor Therapy Hope S. Rugo, MD, FASCO, City of Hope
10:30 AMBreast Cancer Biomarkers: A Review and Update Fan Fang, MD, PhD, City of Hope
11:00 AMExhibits/Break
11:45 AMLung Cancer Biomarkers:​ Role of Immunohistochemistry Leonidas Arvanitis, MD, City of Hope
12:15 PMAdvancing Precision Medicine in Lung Cancer Christine Lovly, MD, PhD, FASCO, City of Hope
12:45 PM Colorectal Cancer: Biomarkers & Methodologies Stanley Hamilton, MD, FCAP, AGAF, City of Hope
1:15 PM Recent Advances in Colorectal Care Marwan G. Fakih, MD, City of Hope
1:45 PMExhibits/Lunch
2:15 PMNon-CME Session – The Value of Molecular Testing: Improving Clinical Outcomes with Precision Oncology Eric Vail, MD, Cedars-Sinai Medical Center
3:00 PMExhibits/Break
3:30 PMThe Germline and Somatic Testing Interface in Oncology Ilana Solomon, MA, ScM, CGC, City of Hope
4:00 PMDigital Pathology – the Next Steps Eric F. Glassy, MD, FCAP, Affiliated Pathologists Medical Group
4:30 PMPanel Discussion Oncology & Pathology Stephen Gruber, MD, PhD, MPH, City of Hope
5:00 PMClosing Remarks

  • Integrate evidence-based advances from both pathology and oncology to enhance biomarker testing, diagnosis, and treatment planning for solid tumors and hematologic malignancies.

  • Apply multidisciplinary insights and new clinical data to improve therapeutic decision-making and patient outcomes across diverse practice settings.

View Here!

View Here!

How to Get Your Certificate
1. Go to kc.cmecertificateonline.com
2. Click on the 2026 Los Angeles – Advancing the Diagnostic-to-Treatment Continuum in Cancer Care link.
3. Evaluate the meeting.
4. Print, download, or save your certificate for your records.
5. If you lose your certificate, or need help, go to help.cmecertificateonline.com

February 28, 2026
9:00 AMBreakfast/Exhibits/Registration
9:25 AMWelcome and Introductions
9:30 AMPrecision Medicine at the Frontier of Oncology Stephen Gruber, MD, PhD, MPH, City of Hope
10:00 AMRole of Immune Therapy in NSCLC and the Potential for Overcoming Resistance Ravi Salgia, MD, PhD, City of Hope
10:30 AMMRD – GI  N. Jewel Samadder, MD, Mayo Clinic, Phoenix, AZ
11:00 AMExhibits/Breakfast
11:30 AMA Pathologist’s Perspective on Diagnosis and Predictive Biomarkers in Leukemia M. James You, MD, PhD, City of Hope
12:00 PMLeukemia Guido Marcucci, MD, City of Hope 
12:30 PMEarly Detection – Challenges and Opportunities Kevin McDonnell, MD, PhD, City of Hope
1:00 PM Melanoma Biomarkers for Clinical Decision Making and Improved Outcomes Joanne M. Jeter, MD, MS, FASCO, City of Hope
1:30 PMAdjourn

Speakers

CO-CHAIR

Eric F. Glassy, MD, FCAP

Medical Director
Affiliated Pathologists Medical Group

CO-CHAIR

Stephen Gruber, MD, PhD, MPH

Vice President
City of Hope National Medical Center

Fang Fan, MD, PhD

Clinical Professor
Director of Cytopathology
City of Hope

Marwan G. Fakih, MD

Co-Director
Gastrointestinal Cancer Program
City of Hope

Stanley Hamilton, MD, FCAP, AGAF

Professor
Department of Pathology
City of Hope

Joanne M. Jeter, MD, MS, FASCO

Clinical Professor
Department of Medical Oncology & Therapeutics Research
City of Hope

Christine Lovly, MD, PhD, FASCO

Division Chief of Thoracic Medical Oncology
City of Hope

Guido Marcucci, MD

Professor and Chair
Department of Hematologic Malignancies Translational Science
City of Hope

Hope S. Rugo, MD, FASCO

Division Chief
Breast Medical Oncology
City of Hope

Ravi Salgia, MD, PhD

Professor and Chair
Medical Oncology & Therapeutics Research
City of Hope

Ilana Solomon, MA, ScM, CGC

Deputy Director, Center for Precision Medicine
City of Hope

Eric Vail, MD

Director
Molecular Pathology
Cedars-Sinai Medical Center

M. James You, MD, PhD

Professor and Chair
Department of Pathology
City of Hope National Medical Center

N. Jewel Samadder, MD, MSc

Professor and Consultant
Gastroenterology and Hepatology
Mayo Clinic, Arizona

Leonidas Arvanitis, MD

Associate Clinical Professor
Department of Pathology
City of Hope

Kevin McDonnell, MD, PhD

Assistant Professor
Department of Medical Oncology & Therapeutics Research
City of Hope

THE LOCATION

Le Meridien
130 W. Huntington Drive
Arcadia, CA  91007
Grandstand Ballroom

REGISTRATION

SPONSOR

Interested in sponsoring the event? Email Gary King by using the link below!

Sponsor